Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126907661 | 12690766 | 1 | I | 20160319 | 20160816 | 20160826 | 20160826 | EXP | GB-TEVA-687435ACC | TEVA | 34.00 | YR | F | Y | 0.00000 | 20160826 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126907661 | 12690766 | 1 | PS | CLOTRIMAZOLE. | CLOTRIMAZOLE | 1 | 500 MG, USED APPROXIMATELY 3 TIMES | U | U | 73306 | 500 | MG | |||||||
126907661 | 12690766 | 2 | SS | FLUCONAZOLE. | FLUCONAZOLE | 1 | 150 MG, ONCE | U | U | 74681 | 150 | MG | CAPSULE | 1X | |||||
126907661 | 12690766 | 3 | SS | FLUCONAZOLE. | FLUCONAZOLE | 1 | 150 MG, ONCE | U | U | 74681 | 150 | MG | 1X | ||||||
126907661 | 12690766 | 4 | SS | CANESTEN | CLOTRIMAZOLE | 1 | Vaginal | 2 DF, ONCE | U | U | BXH9NG2 | 0 | 2 | DF | TABLET | 1X |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126907661 | 12690766 | 1 | Vulvovaginal candidiasis |
126907661 | 12690766 | 2 | Vulvovaginal candidiasis |
126907661 | 12690766 | 3 | Vulvovaginal candidiasis |
126907661 | 12690766 | 4 | Vulvovaginal candidiasis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126907661 | 12690766 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126907661 | 12690766 | Asthenia | |
126907661 | 12690766 | Chest pain | |
126907661 | 12690766 | Drug hypersensitivity | |
126907661 | 12690766 | Drug ineffective | |
126907661 | 12690766 | Dyspnoea | |
126907661 | 12690766 | Laryngotracheal oedema | |
126907661 | 12690766 | Product use issue | |
126907661 | 12690766 | Swollen tongue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126907661 | 12690766 | 1 | 201511 | 201601 | 0 | |
126907661 | 12690766 | 2 | 201601 | 201601 | 0 | |
126907661 | 12690766 | 3 | 201604 | 201604 | 0 | |
126907661 | 12690766 | 4 | 20160319 | 20160320 | 0 |